Entera Bio Ltd. (NASDAQ:ENTX) Sees Significant Increase in Short Interest

Entera Bio Ltd. (NASDAQ:ENTX) was the target of a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 52,600 shares, an increase of 19.0% from the October 31st total of 44,200 shares. Based on an average daily volume of 64,200 shares, the short-interest ratio is currently 0.8 days.

Entera Bio Stock Performance

NASDAQ ENTX opened at $1.64 on Friday. Entera Bio has a 52-week low of $0.52 and a 52-week high of $3.35. The company has a 50-day simple moving average of $1.79 and a 200 day simple moving average of $1.87.

Institutional Investors Weigh In On Entera Bio

Large investors have recently modified their holdings of the stock. Parkman Healthcare Partners LLC lifted its stake in Entera Bio by 2.4% in the third quarter. Parkman Healthcare Partners LLC now owns 411,076 shares of the company’s stock valued at $781,000 after purchasing an additional 9,558 shares during the last quarter. Signature Estate & Investment Advisors LLC bought a new stake in shares of Entera Bio in the third quarter valued at $90,000. Finally, Virtu Financial LLC purchased a new position in shares of Entera Bio during the 1st quarter valued at $37,000. Hedge funds and other institutional investors own 14.11% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright restated a “buy” rating and issued a $10.00 price objective on shares of Entera Bio in a research note on Monday, November 11th.

About Entera Bio

Entera Bio Ltd., a clinical-stage company, focuses on the development and commercialization of orally delivered peptide and protein therapeutics for unmet medical needs. The company's product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of stress fractures.